Pharmaceutical News and Articles

New Pooled Analysis Published in The Lancet Demonstrated Reduced Risk of Combined CV Death or Worsening Heart Failure with Semaglutide

Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure with mildly reduced ejection fraction or heart failure with

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

PASADENA, Calif. (BUSINESS WIRE) Sep. 2, 2024 Arrowhead Pharmaceuticals, Inc. (NASDAQ ARWR) today announced results from the Phase 3 PALISADE study of investiga

FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication

Johnson & Johnson Seeks First Approval of Nipocalimab to Treat Broadest Population Living with Antibody Positive Generalized Myasthenia Gravis

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

What Is the EEE Mosquito-Borne Virus?

New England is on alert following one death and a handful of infections of eastern equine encephalitis (EEE) virus. A New Hampshire resident died after contract

False-Positive Mammogram Result Has Many Women Quitting Mammography

A significant number of women stop getting regular mammograms after being frightened by a false positive scan that incorrectly suggests they have breast cancer,

Researchers Pinpoint Genes Behind Form of Early Menopause

Cases of menopause occurring before the age of 40 can be a major cause of distress and discomfort for women, but researchers now believe they ve homed in on the